The mortality rate due to genitourinary system diseases in the US is projected to rise steadily from 41,840 male deaths in 2024 to 45,480 by 2028. This represents a consistent year-on-year increase, with the death toll rising by slightly over 2% each year. The compound annual growth rate (CAGR) from 2024 to 2028 stands at approximately 2.10%, suggesting a modest upward trend in mortality numbers.

Future Trends to Watch for:

Advancements in medical treatments and early diagnosis impacting mortality rates.
Public health initiatives focusing on preventive care to potentially alter future forecasts.
Demographic shifts, such as an aging population, potentially increasing vulnerability to these diseases.